Nasilin, Baby Boy .

HRN: 28-52-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/06/2026
02/13/2026
IVTT
45mg
Q24h
PSNB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: